{
  "@context": "https://schema.org",
  "@graph": [
    {
      "@type": "Organization",
      "@id": "https://www.transposonrx.com/#organization",
      "name": "Transposon Therapeutics, Inc.",
      "url": "https://www.transposonrx.com/",
      "description": "Transposon Therapeutics, Inc. is developing TPN-101 (also known as Censavudine) and other LINE-1 reverse transcriptase inhibitors for the treatment of rare neurodegenerative diseases such as progressive supranuclear palsy (PSP), amyotrophic lateral sclerosis (ALS), and frontotemporal dementia (FTD)."
    },
    {
      "@type": "WebPage",
      "@id": "https://directory.websdocs.com/business/transposon-therapeutics-inc#asg",
      "name": "Transposon Therapeutics, Inc. ASG Directory Profile",
      "url": "https://directory.websdocs.com/business/transposon-therapeutics-inc",
      "isPartOf": {
        "@id": "https://www.transposonrx.com/#organization"
      },
      "description": "Public business information published by the WebsDocs ASG Directory."
    }
  ]
}